Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Smart technology helps scientists enhance high-value algae

Smart technology helps scientists enhance high-value algae



Photobioreactor Mike Packer

New Zealand’s lucrative blue-biotech sector has received a boost with the launch of a highly- sophisticated, multi-vessel photobioreactor (PBR).

The technology has been designed and built by Cawthron Institute, New Zealand’s largest independent science organisation, to enhance the production of valuable products and healthy food ingredients from algae.

“We developed this technology in response to industry partner’s needs to rapidly optimise growth conditions and uses for algal product development. It will help advance their operations so they can remain at the forefront of international markets,” Cawthron scientist Mike Packer says.

“We are now focusing on using this new photobioreactor to develop high-value products for our clients and optimising their processes.”

Photobioreactors are equipment for growing algae and other phototrophic microorganisms that need light energy to grow. They are used in many industries worldwide and are highly desirable for growing algae for export products.

At Cawthron, scientists use PBRs to trial algal growth models which can then be scaled up for commercial use by industry partners.

“We specialise in PBR technology and have them in many different shapes and sizes but none as capable as this,” Dr Packer says.

“This new system speeds up our ability to gather information so we can understand how to make the algae grow better and how conditions affect behaviour so it produces desirable molecules such as bioactives, antioxidants, cosmetic and key nutritional ingredients used by the nutraceutical, cosmeceutical, biotechnology and aquaculture sectors.”

One of Cawthron’s key clients is nutraceutical company Supreme Biotechnology Ltd which grows and extracts the high-value algae compound astaxanthin on a commercial scale for the global market. The company can already see potential for the new technology.

“We are excited about this development by the Cawthron and we’re keen to utilise their expertise and equipment to optimise our algae growth on a commercial scale. Cawthron have been an essential partner in our journey so far, and will continue to be,” Supreme Biotechnologies Chief Executive Tony Dowd says.

A multidisciplinary team of scientists including mathematicians, engineers and biologists helped design, develop and refine the device over the past three years.

Background:

- Cawthron is New Zealand’s largest independent science organisation, specialising in research that protects the environment and supports sustainable development of primary industries.

- It is a world-leader in microalgae and algal technologies particularly in harmful algal blooms and extraction of high value compounds from algae.

- Cawthron works alongside a number of New Zealand biotechnology companies and its expertise is helping keep New Zealand at the forefront of the global biotechnology industry.

- In 2011 Cawthron launched Cawthron Natural Compounds, an initiative focused on extracting minute amounts of complex organic compounds sourced from algae and selling them to international markets. Cawthron is one of just a handful of organisations worldwide with the capability to produce these rare, naturally occurring compounds and bring them to market.

ENDS


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Auckland Outage: Power Mostly Restored Overnight

Vector wishes to advise that all but 324 customers have been restored overnight. These customers are spread throughout the network in small pockets. The main St Johns feeder was restored around midnight allowing most of the customers in all affected areas to have power this morning. More>>

ALSO:

Half Empty: Dairy Prices Drop To Lowest Since August 2009

Dairy product prices fell to the lowest level in more than five years in the latest GlobalDairyTrade auction, led by declines in butter milk powder and whole milk powder. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
More RSS  RSS
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news